netFormulary
 Report : A-Z HCD items in Formulary 27/11/2020 03:02:43
[Back]
 
Section Status BlueTeq Name
08.01.05 Formulary BlueTeq Abemaciclib tabs 
08.03.04.02 Formulary BlueTeq Abiraterone tabs 
11.99.99.99 Formulary BlueTeq Adalimumab injection uveitis
13.05.03 Formulary BlueTeq Adalimumab injection Hidradenitis suppurativa
08.01.05 Formulary BlueTeq Alectinib caps 
08.02.03 Formulary BlueTeq Alemtuzumab injection multiple sclerosis
10.01.03 Formulary BlueTeq Anakinra injection Adult-Onset Still's Disease
08.01.05 Formulary BlueTeq Arsenic trioxide injection 
08.01.05 Formulary BlueTeq Atezolizumab injection lung cancer indications
08.01.05 Formulary BlueTeq Atezolizumab injection breast cancer indications
08.01.05 Formulary BlueTeq Atezolizumab injection urothelial cancer indications
08.01.05 Formulary BlueTeq Avelumab injection  renal cell carcinoma
08.01.05 Formulary BlueTeq Avelumab injection  
08.01.05 Formulary BlueTeq Axicabtagene ciloleucel cells dispersion for infusion 
08.01.05 Formulary BlueTeq Axitinib tabs 
05.01.09 Formulary BlueTeq Bedaquiline tabs Sirturo®
10.01.03 Restricted Use BlueTeq Belimumab injection 
08.01.01 Formulary BlueTeq Bendamustine injection 
08.01.01 Formulary BlueTeq Bendamustine injection B-cell lymphoma
03.04.02 Formulary BlueTeq Benralizumab injection 
08.01.05 Formulary BlueTeq Bevacizumab injection licensed use
08.01.05 Formulary BlueTeq Binimetinib tabs 
08.02.03 Formulary BlueTeq Blinatumomab injection 
08.01.05 Formulary BlueTeq Bortezomib injection 
02.05.01 Restricted Use BlueTeq Bosentan tabs digital ulcer disease - off-label
08.01.05 Formulary BlueTeq Bosutinib tabs 
08.01.05 Formulary BlueTeq Brentuximab injection 
08.01.05 Formulary BlueTeq Brigatinib tabs 
03.04.03 Formulary BlueTeq C1 esterase inhibitor injection 
08.01.05 Formulary BlueTeq Cabazitaxel injection 
08.01.05 Formulary BlueTeq Cabozantinib caps Cometriq - thyroid cancer
08.01.05 Formulary BlueTeq Cabozantinib tablets Cabometyx - renal carcinoma
04.06 Formulary BlueTeq Cannabidiol solution Epidyolex
08.01.05 Formulary BlueTeq Carfilzomib injection  
08.01.05 Formulary BlueTeq Cemiplimab injection  
08.01.05 Formulary BlueTeq Ceritinib caps 
08.01.05 Formulary BlueTeq Cetuximab injection colorectal cancer
08.01.05 Formulary BlueTeq Cetuximab injection head and neck cancer
01.09.01 Formulary BlueTeq Chenodeoxycholic acid capsules 
01.09.01 Formulary BlueTeq Cholic acid capsules 
08.02.04 Formulary BlueTeq Cladribine tabs multiple sclerosis
04.09.01 Formulary BlueTeq Co-careldopa intestinal gel Duodopa®
08.01.05 Formulary BlueTeq Crizotinib caps 
08.01.03 Formulary BlueTeq Cytarabine and daunorubicin (liposomal) injection Vyxeos®
08.01.05 Formulary BlueTeq Dabrafenib caps 
08.01.05 Formulary BlueTeq Dacomitinib caps 
08.02.04 Formulary BlueTeq Daratumumab injection 
08.01.05 Formulary BlueTeq Dasatinib tabs 
02.08.01 Formulary BlueTeq Defibrotide infusion 
05.01.09 Formulary BlueTeq Delamanid tabs Deltyba®
08.02.04 Formulary BlueTeq Dimethyl fumarate caps Tecfidera - multiple sclerosis
08.01.02 Formulary BlueTeq Doxorubicin hydrochloride pegylated liposomal injection 
08.01.05 Formulary BlueTeq Durvalumab injection 
09.01.03 Formulary BlueTeq Eculizumab injection prevention and management of delayed haemolytic transfusion reactions
09.01.03 Formulary BlueTeq Eculizumab injection Atypical Haemolytic Uraemic Syndrome [aHUS]
09.01.03 Restricted Use BlueTeq Eculizumab injection C3 glomerulopathy post-kidney transplant
09.01.03 Formulary BlueTeq Emicizumab injection 
08.01.05 Formulary BlueTeq Encorafenib caps 
08.01.05 Formulary BlueTeq Entrectinib caps 
08.01.05 Formulary BlueTeq Entrectinib caps non-small cell lung cancer
05.03.03.02 Formulary BlueTeq Epclusa® tabs sofosbuvir and velpatasvir
08.01.05 Formulary BlueTeq Eribulin injection 
09.05.01.02 Formulary BlueTeq Etelcalcetide injection 
08.01.05 Formulary BlueTeq Everolimus tabs breast cancer
08.01.05 Formulary BlueTeq Everolimus tabs neuroendocrine tumours
08.01.05 Formulary BlueTeq Everolimus tabs seizures associated with tuberous sclerosis complex
08.01.05 Formulary BlueTeq Everolimus tabs renal cancer
08.02.04 Formulary BlueTeq Fingolimod caps 
08.03.04.01 Formulary BlueTeq Fulvestrant injection 
08.02.03 Formulary BlueTeq Gemtuzumab ozogamicin infusion 
08.01.05 Formulary BlueTeq Gilteritinib tabs 
08.02.04 Formulary BlueTeq Glatiramer acetate injection 
05.03.03.02 Formulary BlueTeq Harvoni® tabs sofosbuvir and ledipasvir
08.01.05 Formulary BlueTeq Ibrutinib caps 
08.01.05 Formulary BlueTeq Inotuzumab ozogamicin injection 
08.02.04 Formulary BlueTeq Interferon beta-1a injection multiple sclerosis
08.02.04 Formulary BlueTeq Interferon beta-1b injection multiple sclerosis
08.01.05 Formulary BlueTeq Ipilimumab injection 
05.02.01 Formulary BlueTeq Isavuconazole tabs, injection 
08.02.04 Formulary BlueTeq Ixazomib caps 
03.04.03 Formulary BlueTeq Lanadelumab injection 
08.01.05 Formulary BlueTeq Larotrectinib oral solution 
08.02.04 Formulary BlueTeq Lenalidomide caps licensed use
08.01.05 Formulary BlueTeq Lenvatinib caps thyroid cancer - Lenvima®
08.01.05 Formulary BlueTeq Lenvatinib caps renal cancer - Kisplyx®
08.01.05 Formulary BlueTeq Lenvatinib caps hepatocellular carcinoma - Lenvima®
05.03.02.02 Formulary BlueTeq Letermovir tabs, injection 
08.01.05 Formulary BlueTeq Lorlatinib tabs Non-small-cell lung cancer
08.01.05 Formulary BlueTeq Lutetium (177Lu) oxodotreotide injection 
03.07 Formulary BlueTeq Mannitol inhalation powder Bronchitol®
05.03.03.02 Formulary BlueTeq Maviret® tabs glecaprevir and pibrentasvir
03.04.02 Formulary BlueTeq Mepolizumab injection 
10.02.02 Formulary BlueTeq Mexiletine caps congenital myotonia
08.01.05 Formulary BlueTeq Midostaurin caps 
08.02.04 Restricted Use BlueTeq Natalizumab injection 
08.01.05 Formulary BlueTeq Neratinib tabs 
08.01.05 Formulary BlueTeq Nilotinib caps 
03.11 Formulary BlueTeq Nintedanib caps Ofev® - idiopathic pulmonary fibrosis
08.01.05 Formulary BlueTeq Niraparib caps 
08.01.05 Formulary BlueTeq Nivolumab injection head and neck, renal and skin cancer
08.01.05 Formulary BlueTeq Nivolumab injection urothelial cancer
08.01.05 Formulary BlueTeq Nivolumab injection haematological and lung cancer
01.09.01 Formulary BlueTeq Obeticholic acid tabs 
08.02.03 Formulary BlueTeq Obinutuzumab injection 
08.02.04 Formulary BlueTeq Ocrelizumab injection 
08.01.05 Formulary BlueTeq Olaparib tabs 
03.04.02 Restricted Use BlueTeq Omalizumab injection asthma
08.01.05 Formulary BlueTeq Osimertinib tabs 
08.01.05 Formulary BlueTeq Paclitaxel albumin injection Abraxane
08.01.05 Formulary BlueTeq Palbociclib tabs 
08.01.05 Formulary BlueTeq Panitumumab injection 
08.03.04.03 Formulary BlueTeq Pasireotide injection 
08.02.04 Formulary BlueTeq Peginterferon beta-1a injection 
06.05.01 Formulary BlueTeq Pegvisomant injection 
08.01.05 Formulary BlueTeq Pembrolizumab injection skin cancer indications
08.01.05 Formulary BlueTeq Pembrolizumab injection lymphoma and lung cancer indications
08.01.05 Formulary BlueTeq Pembrolizumab injection urothelial cancer indications
08.01.03 Formulary BlueTeq Pemetrexed injection 
08.01.05 Formulary BlueTeq Pertuzumab injection 
03.11 Formulary BlueTeq Pirfenidone caps 
09.01.07 Restricted Use BlueTeq Plerixafor injection 
08.01.05 Formulary BlueTeq Polatuzumab vedotin injection 
08.02.04 Formulary BlueTeq Pomalidomide caps 
08.01.05 Formulary BlueTeq Ponatinib tabs 
03.04.03 Formulary BlueTeq Recombinant C1 esterase inhibitor injection Ruconest, Conestat Alpha
08.01.05 Formulary BlueTeq Regorafenib tabs gastrointestinal stromal tumours
08.01.05 Formulary BlueTeq Regorafenib tabs hepatocellular carcinoma
03.04.02 Formulary BlueTeq Reslizumab injection 
08.01.05 Formulary BlueTeq Ribociclib tabs 
10.01.03 Formulary BlueTeq Rituximab injection ANCA vasculitis
10.01.03 Restricted Use BlueTeq Rituximab injection rheumatology - off-label indications
10.02.01 Formulary BlueTeq Rituximab injection myaesthenia gravis - off-label
13.05.03 Formulary BlueTeq Rituximab injection dermatology indications
08.02.03 Formulary BlueTeq Rituxmab injection anti-NMDAR autoimmune encephalitis - off-label
08.01.05 Formulary BlueTeq Rucaparib tabs 
08.01.05 Formulary BlueTeq Sorafenib tablets Hepatocellular carcinoma
08.01.05 Formulary BlueTeq Sorafenib tablets thyroid cancer
08.01.05 Formulary BlueTeq Sunitinib caps renal cell carcinoma
08.01.05 Formulary BlueTeq Sunitinib caps gastrointestinal stromal tumours and neuroendocrine tumours
08.01.05 Formulary BlueTeq Talimogene laherparepvec injection 
08.02.04 Formulary BlueTeq Teriflunomide tablets 
08.01.05 Formulary BlueTeq Tisagenlecleucel cells dispersion for infusion 
08.01.05 Formulary BlueTeq Tivozanib caps 
10.01.03 Formulary BlueTeq Tocilizumab COVID-19 pneumonia [ICU only] - off-label
10.01.03 Formulary BlueTeq Tocilizumab cytokine relsease syndrome following CAR T-cell therapy
10.01.03 Formulary BlueTeq Tocilizumab injection Adult-Onset Still's Disease
10.01.03 Formulary BlueTeq Tocilizumab subcutaneous injection giant cell arteritis
08.01.05 Formulary BlueTeq Trametinib tabs 
08.01.05 Formulary BlueTeq Trastuzumab emtansine injection  
08.01.01 Formulary BlueTeq Treosulfan injection 
09.08.01 Formulary BlueTeq Trientine dihydrochloride tabs 
08.01.03 Formulary BlueTeq Trifluridine–tipiracil tablets 
08.01.05 Formulary BlueTeq Venetoclax tabs 
05.03.03.02 Formulary BlueTeq Vosevi® tabs sofosbuvir, velpatasvir and voxilaprevir
05.03.03.02 Formulary BlueTeq Zepatier® tabs elbasvir and grazoprevir
South East London Joint Medicines Formulary